Atlas Trials

Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis

Clinical trial NCT04834401 · COMPLETED

Trial details

NCT number
NCT04834401
Sponsor
St. Barnabas Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple SclerosisCovid19
Start date
2021-03-22
Primary completion
2022-05-17
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.